Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
Epilepsy & Behavior : E&B|June 27, 2024
Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disabilityJon Allard, William Henley, Adrian Sellers, et al.
Epilepsia|January 29, 2025
Prioritizing questions and topics for the development of guidelines and consensus-based recommendations supported by ILAE: A scoping review and proposal of prioritization criteriaKatia Lin, Sara Eyal, Izabel Galhardo Demarchi, et al.
Global Epidemiology|January 26, 2026
Modelling seizure-related predictors of epilepsy diagnostic gap in two urban informal settlements of Nairobi using machine learningDaniel Mwanga, Frederick Murunga Wekesah, Frank Ouma, et al.
Developmental Medicine and Child Neurology|November 21, 2012
The clinical utility of an SCN1A genetic diagnosis in infantile-onset epilepsyAndreas Brunklaus, Liam Dorris, Rachael Ellis, et al.
Annals of Clinical and Translational Neurology|October 17, 2019
Hippocampal epileptogenesis in autoimmune encephalitisMichele Romoli, Paraskevi Krashia, Arjune Sen, et al.
Seizure|April 27, 2019
Perampanel for the treatment of epilepsy; Longitudinal actuarial analysis and dose responses based on monthly outcomesIoannis Stavropoulos, Walter Louden, Cathy Queally, et al.
Seizure|June 19, 2024
Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: A naturalistic case control studyJon Allard, Adrian Sellers, William Henley, et al.
BMC Public Health|September 28, 2024
Attitudes and perceptions towards epilepsy in an onchocerciasis-endemic region of Tanzania: a mixed approach to determine the magnitude and driving factorsVivian P Mushi, Winifrida Kidima, Isolide S Massawe, et al.
Epilepsia|May 3, 2022
International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and DefinitionsKate Riney, Alicia Bogacz, Ernest Somerville, et al.
JAMA Neurology|May 2, 2022
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical TrialKelly G Knupp, Ingrid E Scheffer, Berten Ceulemans, et al.
Pageof 22